Skip to main content

Table 4 Differences between groups regarding primary and secondary outcome measures

From: The effectiveness of the Austrian disease management programme for type 2 diabetes: a cluster-randomised controlled trial

 

mean difference1

95%-CI

p-value2

Primary outcome measure

HbA1c (%)

-0.13

[-0.24; -0.02]

0.026

Secondary outcome measures

Creatinine (μmol/l)

1.77

[-0.88; 4.42]

0.157

Triglycerides (mmol/l)

-0.06

[-0.21; 0.09]

0.417

Cholesterol (mmol/l)

-0.05

[-0.16; 0.05]

0.291

HDL (mmol/l)

0.01

[-0.01; 0.04]

0.295

LDL (mmol/l)

0.05

[-0.04; 0.14]

0.314

RR systolic (mmHg)

-1.80

[-3.65; 0.05]

0.057

RR diastolic (mmHg)

-0.55

[-1.62; 0.51]

0.307

BMI

-0.27

[-0.45; -0.08]

0.004

  1. 1 Mean difference is calculated as control group value - intervention group value.
  2. 2 independent T-Test, unadjusted